Procter & Gamble [PGHL] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison
Procter & Gamble
NSE
Loading...
Sun Pharma Advanced
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Procter & Gamble wins in 12 metrics, Sun Pharma Advanced wins in 6 metrics, with 0 ties. Procter & Gamble appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Procter & Gamble | Sun Pharma Advanced | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 57.14 | -13.71 | Sun Pharma Advanced |
| Price-to-Book Ratio | 19.56 | -21.61 | Sun Pharma Advanced |
| Debt-to-Equity Ratio | 0.01 | -1.24 | Sun Pharma Advanced |
| PEG Ratio | -4.58 | 0.30 | Procter & Gamble |
| EV/EBITDA | 31.97 | -17.41 | Sun Pharma Advanced |
| Profit Margin (TTM) | 20.62% | -53.22% | Procter & Gamble |
| Operating Margin (TTM) | 25.06% | -568.05% | Procter & Gamble |
| EBITDA Margin (TTM) | 25.06% | N/A | N/A |
| Return on Equity | 37.41% | 157.88% | Sun Pharma Advanced |
| Return on Assets (TTM) | 25.30% | -102.08% | Procter & Gamble |
| Free Cash Flow (TTM) | $2.07B | $-3.71B | Procter & Gamble |
| Dividend Yield | 2.35% | N/A | N/A |
| 1-Year Return | 23.04% | -36.06% | Procter & Gamble |
| Price-to-Sales Ratio (TTM) | 8.64 | 73.56 | Procter & Gamble |
| Enterprise Value | $103.00B | $49.38B | Procter & Gamble |
| EV/Revenue Ratio | 9.12 | 76.45 | Procter & Gamble |
| Gross Profit Margin (TTM) | 72.25% | -10.68% | Procter & Gamble |
| Revenue per Share (TTM) | $734 | $2 | Procter & Gamble |
| Earnings per Share (Diluted) | $111.00 | $-9.18 | Procter & Gamble |
| Beta (Stock Volatility) | 0.43 | 0.30 | Sun Pharma Advanced |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Procter & Gamble vs Sun Pharma Advanced Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Procter & Gamble | 1.14% | 1.49% | 4.73% | 15.88% | 26.21% | 23.86% |
| Sun Pharma Advanced | -1.00% | 0.44% | 1.78% | -12.58% | 14.95% | -27.77% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Procter & Gamble | 23.04% | 50.69% | 32.13% | 766.10% | 792.71% | 1,236.02% |
| Sun Pharma Advanced | -36.06% | -34.69% | -19.39% | -61.35% | 59.68% | -50.27% |
News Based Sentiment: Procter & Gamble vs Sun Pharma Advanced
Procter & Gamble
News sentiment data is not available for Procter & Gamble at this time.
Sun Pharma Advanced
News based Sentiment: MIXED
SPARC experienced both positive and negative developments in September, including a temporary share price increase followed by a decline, alongside continued losses and fluctuating investor activity. While cost-cutting measures are showing some effect, revenue remains a significant concern, creating a mixed investment picture.
Performance & Financial Health Analysis: Procter & Gamble vs Sun Pharma Advanced
| Metric | PGHL | SPARC |
|---|---|---|
| Market Information | ||
| Market Cap | ₹105.29B | ₹46.73B |
| Market Cap Category | Mid cap | Small cap |
| 10 Day Avg. Volume | 43,440 | 193,908 |
| 90 Day Avg. Volume | 22,723 | 226,143 |
| Last Close | ₹6,370.00 | ₹143.10 |
| 52 Week Range | ₹4,863.00 - ₹6,739.00 | ₹109.30 - ₹241.00 |
| % from 52W High | -5.48% | -40.62% |
| All-Time High | ₹7,500.00 (Feb 08, 2021) | ₹875.00 (Apr 24, 2006) |
| % from All-Time High | -15.07% | -83.65% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.19% | -0.43% |
| Quarterly Earnings Growth | 2.94% | -0.43% |
| Financial Health | ||
| Profit Margin (TTM) | 0.21% | -0.53% |
| Operating Margin (TTM) | 0.25% | -5.68% |
| Return on Equity (TTM) | 0.37% | 1.58% |
| Debt to Equity (MRQ) | 0.01 | -1.24 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹324.25 | ₹-6.69 |
| Cash per Share (MRQ) | N/A | ₹0.06 |
| Operating Cash Flow (TTM) | ₹3.20B | ₹-3,484,287,000 |
| Levered Free Cash Flow (TTM) | ₹2.01B | ₹-3,425,094,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.35% | N/A |
| Last 12-Month Dividend | ₹140.00 | N/A |
Valuation & Enterprise Metrics Analysis: Procter & Gamble vs Sun Pharma Advanced
| Metric | PGHL | SPARC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 57.14 | -13.71 |
| Forward P/E | N/A | 2.64 |
| PEG Ratio | -4.58 | 0.30 |
| Price to Sales (TTM) | 8.64 | 73.56 |
| Price to Book (MRQ) | 19.56 | -21.61 |
| Market Capitalization | ||
| Market Capitalization | ₹105.29B | ₹46.73B |
| Enterprise Value | ₹103.00B | ₹49.38B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 9.12 | 76.45 |
| Enterprise to EBITDA | 31.97 | -17.41 |
| Risk & Other Metrics | ||
| Beta | 0.43 | 0.30 |
| Book Value per Share (MRQ) | ₹324.25 | ₹-6.69 |
Financial Statements Comparison: Procter & Gamble vs Sun Pharma Advanced
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | PGHL | SPARC |
|---|---|---|
| Revenue/Sales | ₹3.39B | ₹96.40M |
| Cost of Goods Sold | ₹939.90M | ₹106.70M |
| Gross Profit | ₹2.45B | ₹-10.30M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹849.00M | ₹-547.60M |
| EBITDA | ₹943.70M | ₹-429.40M |
| Pre-Tax Income | ₹888.10M | ₹-518.10M |
| Income Tax | ₹226.30M | ₹600,000 |
| Net Income (Profit) | ₹661.80M | ₹-518.70M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | PGHL | SPARC |
|---|---|---|
| Cash & Equivalents | ₹1.82B | ₹19.64M |
| Total Current Assets | ₹5.26B | ₹261.97M |
| Total Current Liabilities | ₹2.15B | ₹3.74B |
| Long-Term Debt | ₹48.10M | ₹1.07B |
| Total Shareholders Equity | ₹5.37B | ₹-2.17B |
| Retained Earnings | N/A | ₹-23.22B |
| Property, Plant & Equipment | ₹1.11B | ₹178.02M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | PGHL | SPARC |
|---|---|---|
| Operating Cash Flow | ₹711.00M | N/A |
| Capital Expenditures | ₹-32.30M | N/A |
| Free Cash Flow | ₹459.90M | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | PGHL | SPARC |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 43,440 | 193,908 |
| Average Daily Volume (90 Day) | 22,723 | 226,143 |
| Shares Outstanding | 16.60M | 324.52M |
| Float Shares | 7.93M | 91.74M |
| % Held by Insiders | 0.52% | 0.73% |
| % Held by Institutions | 0.16% | 0.02% |
Dividend Analysis & Yield Comparison: Procter & Gamble vs Sun Pharma Advanced
| Metric | PGHL | SPARC |
|---|---|---|
| Last 12-Month Dividend | ₹140.00 | N/A |
| Last 12-Month Dividend Yield | 2.35% | N/A |
| 3-Year Avg Annual Dividend | ₹98.83 | N/A |
| 3-Year Avg Dividend Yield | 0.99% | N/A |
| 3-Year Total Dividends | ₹296.50 | N/A |
| Ex-Dividend Date | Feb 21, 2025 | N/A |